XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 25.72

+3.5%

11:33 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cacaito who wrote (11392)	8/18/1999 9:29:00 PM
From: aknahow	Read Replies (1) of 17367

I agree the trauma trial could provide very good answers. I still believe that unless the trial is halted for super efficacy I do not think this information will be available to us. Nor do I think it could be sent to the FDA to somehow influence decisions on the meningo trial. BTW Cacaito, I was one of the major promoters of the idea that XOMA should provide us with information when the trial was un blinded. Yes I wanted just the raw numbers. Will miss you and your post greatly. Already do as no one has addressed the neat site Opala and I have been posting about. The sepsis trials url. Still see Mycroprex deal coming and expect it to be big. Still have great expectations for Neuprex. Still like management, but just am not waving a red flag at others on Yahoo, or anywhere since it would do no good at this time.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next